# Otsuka Holdings to acquire ReCor Medical

Otsuka Holdings signed a merger agreement to acquire the remaining shares of ReCor Medical, which develops the Paradise Renal Denervation System for hypertension treatment.

- Type: Acquisition
- Announced: 2018-07-10
- Where: United States
- Status: announced
- Products: Paradise Renal Denervation System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Otsuka Holdings](https://endata.com/companies/33020.md) (acquirer)
- [ReCor Medical](https://endata.com/companies/33021.md) (target)
- [Otsuka Medical Devices](https://endata.com/companies/33022.md) (partner)
- [Sofinnova Partners](https://endata.com/companies/33040.md) (investor)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/otsuka-medical-devices-otsuka-holdings-and-recor-medical-announce-signing-of-merger-agreement-300678265.html), 2018-07-10: "Otsuka Holdings Co., Ltd., Otsuka Medical Devices Co., Ltd. and ReCor Medical, Inc. announce the signing of a merger agreement pursuant to which Otsuka Holdings will acquire the remaining shares in ReCor from its current holders."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/otsuka-medical-devices-merge-us-recor-medical/), 2018-07-10: "Our acquisition of ReCor represents an important step forward for Otsuka's medical device business, leveraging an innovative technology with Otsuka's expertise in pharmaceuticals and clinical development."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.